170 related articles for article (PubMed ID: 17150641)
1. RNA interference induced by siRNAs modified with 4'-thioribonucleosides.
Hoshika S; Minakawa N; Matsuda A
Nucleic Acids Symp Ser (Oxf); 2005; (49):77-8. PubMed ID: 17150641
[TBL] [Abstract][Full Text] [Related]
2. RNA interference induced by siRNAs modified with 4'-thioribonucleosides in cultured mammalian cells.
Hoshika S; Minakawa N; Kamiya H; Harashima H; Matsuda A
FEBS Lett; 2005 Jun; 579(14):3115-8. PubMed ID: 15919084
[TBL] [Abstract][Full Text] [Related]
3. Study of modification pattern-RNAi activity relationships by using siRNAs modified with 4'-thioribonucleosides.
Hoshika S; Minakawa N; Shionoya A; Imada K; Ogawa N; Matsuda A
Chembiochem; 2007 Nov; 8(17):2133-8. PubMed ID: 17924376
[TBL] [Abstract][Full Text] [Related]
4. Improving RNA interference in mammalian cells by 4'-thio-modified small interfering RNA (siRNA): effect on siRNA activity and nuclease stability when used in combination with 2'-O-alkyl modifications.
Dande P; Prakash TP; Sioufi N; Gaus H; Jarres R; Berdeja A; Swayze EE; Griffey RH; Bhat B
J Med Chem; 2006 Mar; 49(5):1624-34. PubMed ID: 16509579
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and properties of modified siRNA having amide-linked oligoribonucleosides at their 3' overhang regions.
Iwase R; Miyao H; Toyama T; Nishimori K
Nucleic Acids Symp Ser (Oxf); 2006; (50):175-6. PubMed ID: 17150874
[TBL] [Abstract][Full Text] [Related]
6. Lipid-mediated siRNA delivery down-regulates exogenous gene expression in the mouse brain at picomolar levels.
Hassani Z; Lemkine GF; Erbacher P; Palmier K; Alfama G; Giovannangeli C; Behr JP; Demeneix BA
J Gene Med; 2005 Feb; 7(2):198-207. PubMed ID: 15515135
[TBL] [Abstract][Full Text] [Related]
7. Solid-phase synthesis of modified RNAs containing amide-linked oligoribonucleosides at their 3'-end and their application to siRNA.
Iwase R; Toyama T; Nishimori K
Nucleosides Nucleotides Nucleic Acids; 2007; 26(10-12):1451-4. PubMed ID: 18066804
[TBL] [Abstract][Full Text] [Related]
8. Intracellular stability of 2'-OMe-4'-thioribonucleoside modified siRNA leads to long-term RNAi effect.
Takahashi M; Nagai C; Hatakeyama H; Minakawa N; Harashima H; Matsuda A
Nucleic Acids Res; 2012 Jul; 40(12):5787-93. PubMed ID: 22411910
[TBL] [Abstract][Full Text] [Related]
9. Effect of siRNA nuclease stability on the in vitro and in vivo kinetics of siRNA-mediated gene silencing.
Bartlett DW; Davis ME
Biotechnol Bioeng; 2007 Jul; 97(4):909-21. PubMed ID: 17154307
[TBL] [Abstract][Full Text] [Related]
10. Functional comparison of single- and double-stranded siRNAs in mammalian cells.
Xu Y; Linde A; Larsson O; Thormeyer D; Elmen J; Wahlestedt C; Liang Z
Biochem Biophys Res Commun; 2004 Apr; 316(3):680-7. PubMed ID: 15033453
[TBL] [Abstract][Full Text] [Related]
11. Allele-specific silencing by RNA interference.
Hohjoh H
Methods Mol Biol; 2010; 623():67-79. PubMed ID: 20217544
[TBL] [Abstract][Full Text] [Related]
12. Influence of assembly of siRNA elements into RNA-induced silencing complex by fork-siRNA duplex carrying nucleotide mismatches at the 3'- or 5'-end of the sense-stranded siRNA element.
Ohnishi Y; Tokunaga K; Hohjoh H
Biochem Biophys Res Commun; 2005 Apr; 329(2):516-21. PubMed ID: 15737617
[TBL] [Abstract][Full Text] [Related]
13. Palmitic acid-conjugated 21-nucleotide siRNA enhances gene-silencing activity.
Kubo T; Yanagihara K; Takei Y; Mihara K; Morita Y; Seyama T
Mol Pharm; 2011 Dec; 8(6):2193-203. PubMed ID: 21985606
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of polyamidoamine dendrimer/alpha-cyclodextrin conjugate (generation 3, G3) as a novel carrier for small interfering RNA (siRNA).
Tsutsumi T; Hirayama F; Uekama K; Arima H
J Control Release; 2007 Jun; 119(3):349-59. PubMed ID: 17477999
[TBL] [Abstract][Full Text] [Related]
15. RNA interference in mammalian cells by siRNAs modified with morpholino nucleoside analogues.
Zhang N; Tan C; Cai P; Zhang P; Zhao Y; Jiang Y
Bioorg Med Chem; 2009 Mar; 17(6):2441-6. PubMed ID: 19233658
[TBL] [Abstract][Full Text] [Related]
16. Studies on aminoisonucleoside modified siRNAs: stability and silencing activity.
Li ZS; Qiao RP; Du Q; Yang ZJ; Zhang LR; Zhang PZ; Liang ZC; Zhang LH
Bioconjug Chem; 2007; 18(4):1017-24. PubMed ID: 17539595
[TBL] [Abstract][Full Text] [Related]
17. Rational design and in vitro and in vivo delivery of Dicer substrate siRNA.
Amarzguioui M; Lundberg P; Cantin E; Hagstrom J; Behlke MA; Rossi JJ
Nat Protoc; 2006; 1(2):508-17. PubMed ID: 17406276
[TBL] [Abstract][Full Text] [Related]
18. SiRNAs conjugated with aromatic compounds induce RISC-mediated antisense strand selection and strong gene-silencing activity.
Kubo T; Yanagihara K; Takei Y; Mihara K; Sato Y; Seyama T
Biochem Biophys Res Commun; 2012 Oct; 426(4):571-7. PubMed ID: 22982308
[TBL] [Abstract][Full Text] [Related]
19. Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA.
Judge AD; Sood V; Shaw JR; Fang D; McClintock K; MacLachlan I
Nat Biotechnol; 2005 Apr; 23(4):457-62. PubMed ID: 15778705
[TBL] [Abstract][Full Text] [Related]
20. Positional effects and strand preference of RNA interference against hepatitis C virus target sequences.
Smith RM; Smolic R; Volarevic M; Wu GY
J Viral Hepat; 2007 Mar; 14(3):194-212. PubMed ID: 17305886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]